Home/Publication/Sherpa et al Bet on Minimally Invasive Heart Therapy
Sherpa et al Bet on Minimally Invasive Heart Therapy 

20 Jan 2026

US$ 20.00

chinaSherpa Healthcare Partners and Guozhong Capital have co-led the over Rmb100 m (US$14.4 m) series A funding round...

Price / article: US$20.00
OR existing subscriber
Related Publications

Subscribers’ Weekly for the week ending 23 Jan 2026...

Jungle Ventures (Jungle) has led the US$25 m series A funding round of Enchante Brands Pvt Ltd, operator of Escape...

Connect With Us

We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.

Rest assured that your email address will not be shared, as we hate spams as much as you do.